Micros vs. Macros: What’s More Important?

Five different symptoms, apparently from different body systems and yet they frequently cluster together in the same person. PCOS, acne, irregular periods, hair loss, and low libido are not disconnected problems requiring separate treatments. They share a common root: hormonal dysregulation, and specifically, the metabolic and inflammatory disruption that drives it.

The Common Thread: Androgen Excess and Insulin Resistance

Androgens (primarily testosterone and its derivative DHT dihydrotestosterone) are essential hormones in both men and women, but they cause problems when present in excess relative to the balance of other sex hormones. The symptoms listed above are the classic presentation of relative androgen excess:

• PCOS: Polycystic ovary syndrome is fundamentally a condition of excess androgen activity, which disrupts ovulation and causes follicle accumulation on the ovaries
• Acne: Androgens drive sebaceous gland activity more androgen means more sebum, more blocked pores, more inflammatory acne
• Irregular periods: Androgen excess suppresses the normal hormonal cycling of the menstrual cycle elevated androgens block the LH surge that triggers ovulation
• Hair loss (androgenic alopecia): DHT causes miniaturisation of hair follicles, particularly in genetically susceptible individuals
• Low libido: Paradoxically, androgen excess in women disrupts the hormonal balance in ways that suppress rather than enhance libido and the systemic inflammation and fatigue that accompany these conditions compound the effect

The critical question is: what drives androgen excess? In most cases, insulin resistance is the primary driver.

Why Insulin Resistance Is the Root

Insulin stimulates the ovaries to produce androgens and also suppresses the production of sex hormone binding globulin (SHBG), the protein that binds testosterone and keeps it inactive. More insulin means more androgen production AND less SHBG to bind it, resulting in higher free (biologically active) testosterone.

Insulin resistance in which cells no longer respond normally to insulin and the pancreas compensates by producing more therefore directly drives androgen excess. This is why insulin-sensitising medications (metformin) are a primary treatment for PCOS: not because PCOS is a diabetes-like condition, but because correcting insulin resistance corrects the androgen excess that drives the symptoms.

The Gut-Hormone Connection

Gut health is central to this cluster of symptoms through multiple mechanisms:

Estrobolome and Hormone Metabolism

The estrobolome the collection of gut bacteria responsible for oestrogen metabolism determines how much oestrogen is reabsorbed from the gut versus excreted. In androgen-dominant states, supporting the estrobolome (through prebiotic fibre and probiotics) helps maintain a healthier oestrogen-androgen balance.

Inflammation and Androgen Sensitivity

Systemic inflammation from gut dysbiosis and increased intestinal permeability increases androgen receptor sensitivity meaning a given amount of testosterone produces a stronger effect on target tissues. Reducing gut-driven inflammation reduces the amplification of androgen effects even without reducing androgen levels.

Gut Bacteria and Insulin Sensitivity

Short-chain fatty acids (produced by gut bacteria fermenting prebiotic fibre) directly improve insulin sensitivity reducing the insulin resistance that drives androgen excess. This creates a clear mechanism by which improving gut health can improve PCOS and its associated symptoms.

What Actually Helps

For this cluster of symptoms, the most impactful interventions address insulin resistance and inflammation:

• Low-glycaemic dietary pattern: Reducing glucose spikes reduces insulin demand, reducing androgen stimulation
• Dietary fibre: Improves insulin sensitivity through SCFA production; supports estrobolome function
• Inositol (particularly myo-inositol and D-chiro-inositol): Strong evidence for PCOS improves insulin signalling, reduces androgens, restores ovulation
• Zinc: Inhibits 5-alpha-reductase (the enzyme that converts testosterone to DHT) relevant to both acne and hair loss
• Magnesium: Improves insulin sensitivity and supports cortisol regulation (cortisol drives androgen production)
• Probiotics and prebiotics: Improve insulin sensitivity and support estrobolome function

GRNS addresses this cluster of symptoms at the foundational level providing prebiotic fibre for estrobolome support and insulin sensitivity, zinc for androgen enzyme inhibition, magnesium for insulin and cortisol regulation, and adaptogen support for the HPA axis that interfaces directly with the HPG axis driving these hormonal patterns. It's a foundational support, not a treatment but foundational support is exactly what this cluster of symptoms requires alongside any medical management.

Frequently Asked Questions

Do I need a PCOS diagnosis to address these symptoms?
Not necessarily. Many women have androgen-dominant hormonal patterns that cause these symptoms without meeting the formal Rotterdam criteria for PCOS diagnosis (which requires two of three: irregular cycles, elevated androgens, and polycystic ovaries on ultrasound). The underlying approach improving insulin sensitivity, supporting gut health, addressing inflammation is relevant regardless of whether a formal diagnosis has been made.

Can men have this cluster of symptoms?
The analogous condition in men involves different presentations primarily insulin resistance-driven low testosterone rather than androgen excess. But acne, hair loss, and metabolic dysfunction with their shared root in insulin resistance and inflammation absolutely affect men. The gut health, dietary, and lifestyle interventions that address these roots are equally relevant for both sexes.

How long does it take to see improvement in these symptoms with a dietary/gut health approach?
Timeline varies by symptom. Acne changes typically become visible within 812 weeks of sustained gut and dietary intervention. Period regularity in PCOS can improve within 36 months as insulin sensitivity improves. Hair loss is the slowest the hair follicle cycle takes 36 months to visibly respond to reduced DHT exposure. Consistent, sustained intervention over 36 months is the minimum assessment period.